Company: CPMV
Filing Date: 2025-04-15
Form Type: 10-K
Source: 0001683168-25-002584
Chunk: 44

Company: Mosaic ImmunoEngineering Inc.
Filing Date: 2025-04-15
Form: 10-K
Item: Item 1
Chunk 44
---
 manage these risks by monitoring these third-party service providers and reviewing SOC reports
of these providers and implementing complementary controls, if necessary. This approach is designed to mitigate risks related to data
breaches or other security incidents originating from third parties.

Risks from Cybersecurity Threats

We have not encountered cybersecurity challenges that
have materially impaired our operations or financial standing.

    ITEM 2.
    PROPERTIES

The Company has no properties at December 31, 2024,
and at the period covered by this Report, has no agreements to acquire any properties. The Company currently uses the home offices of
management at no cost to the Company. The Company expects this arrangement to continue until the Company can raise sufficient capital
and potentially license or acquire new technologies.

    ITEM 3.
    LEGAL PROCEEDINGS

Information pertaining to legal proceedings is provided
in Note 10, Commitments and Contingencies, to the accompanying audited consolidated financial statements and is incorporated by reference
herein.

    ITEM 4.
    MINE SAFETY DISCLOSURES

Not applicable.

 26 

PART II

    ITEM 5.
    MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES

Market Information

Our common stock is currently quoted on the OTC Pink
Open Market (“OTC Pink”) under the trading symbol “CPMV”. There has been a very limited market for our common
stock and our trading volume has been negligible. There is no guarantee that an active trading market will develop in our common stock.
These quotations as reported by the OTC Pink reflect inter-dealer prices without retail mark-up, markdown or commissions and may not necessarily
represent actual transactions. The following table sets forth the range of high and low bid quotations for each of the years ended December
31, 2024 and 2023.

    Bid Quotations 

    High  
    Low 
  
    Year Ended December 31, 2024 

    Quarter Ended March 31, 2024 
    $0.61  
    $0.30 
  
    Quarter Ended June 30, 2024 
    $0.65  
    $0.10 
  
    Quarter Ended September 30, 2024 
    $1.13  
    $0.21 
  
    Quarter Ended December 31, 2024 
    $1.00